Willem van den Brink

Functie:
Senior Scientist Digital Biomarkers

Contact me for collaborations in digital biomarkers, wearable health technology, and data-driven prevention. My work focuses on developing reliable and meaningful digital biomarkers that support the transformation toward preventive and personalized healthcare.

Research area

I work on developing digital biomarkers based on wearable technologies such as smartwatches, smartphones, and medical patches. These enable continuous, non-invasive monitoring of physiological processes. My research combines sensor technology, data science, social innovation, and clinical applications to improve diagnostics and prevention in chronic diseases.

At TNO, I am involved in projects on cardiometabolic diseases, inflammatory conditions, and diabetes. I lead research within the ENGAGE, IBDigital, DIMPLAD, and iCARE4CVD projects, collaborating with public and private partners to validate and implement digital biomarkers in practice. My goal is to make health monitoring accessible, reliable, and personalized, shifting the focus from care to prevention.

Projects

ENGAGE: public-private partnership aimed at developing meaningful digital biomarkers for individuals with type 2 diabetes, with an emphasis on macro- and microvascular complications. ENGAGE incorporates social innovation to integrate the perspectives of individuals with type 2 diabetes and other stakeholders regarding what to measure, how to measure it, and how to use it for self-management, clinical decision-making, and real-world evidence collection.

2DIAREM: public private partnership in developing a digital biomarker for TNO's diabetes subtyping technology. This technology can recognize insulin resistance that is specific to certain organs, allowing for personalized lifestyle recommendations that are more effective in preventing and managing type 2 diabetes. However, because it requires an oral glucose tolerance test and multiple blood samples, it may be difficult to implement on a large scale. Therefore, digital biomarker alternatives that rely on continuous glucose monitoring data are being considered to enhance the usability and scalability of diabetes subtyping.

BioCurity: aims to detect and monitor metabolic syndrome in a secure digital ecosystem. Specifically, I'm responsible for developing and integrating blood pressure variability as a promising digital biomarker for metabolic syndrome and cardiovascular risk.

Prevntion2.0: TNO's Prevention program in collaboration with healthcare key opinion leaders, to create digital biomarkers of inflammation utilizing continuous vital sign monitoring through TNO's Health Patch. The program's focus is on inflammation in cardiometabolic disorder, inflammatory bowel disease, and chronic obstructive pulmonary disease.

Recent publications

Leiden - Sylviusweg

Sylviusweg 71
2333 BE Leiden
The Netherlands